In a 53-year-old male ICU patient with heart failure (ejection fraction 27%), malignant left middle cerebral artery infarct, type 2 diabetes mellitus, pneumonia, acute kidney injury on chronic kidney disease requiring hemodialysis, status post tracheostomy, who has persistent hiccups despite metoclopramide (Plasil) 1 ampoule IV every 8 hours, what additional medications can be used to treat the hiccups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Add Chlorpromazine or Haloperidol for Persistent Hiccups

For your critically ill patient with persistent hiccups despite metoclopramide, add chlorpromazine 25-50 mg IV every 6-8 hours as the next-line agent, or alternatively haloperidol 2-5 mg IV every 8 hours. Both are phenothiazine/butyrophenone antipsychotics with established efficacy for intractable hiccups 1.

Rationale and Mechanism

Chlorpromazine specifically has documented use for intractable hiccups 1. The mechanism involves dopamine receptor antagonism centrally, which interrupts the hiccup reflex arc. Given that metoclopramide (also a dopamine antagonist but primarily prokinetic) has failed, escalation to a more potent central dopamine blocker is the logical next step.

Critical Safety Considerations in Your Patient

Renal Dosing is Mandatory

Your patient is on hemodialysis with AKI on CKD. While the guidelines don't specify exact renal dosing for chlorpromazine in hiccups, start at the lower end (25 mg IV) and monitor closely. Both drugs are partially dialyzed, so timing relative to dialysis sessions matters 2.

QTc Prolongation Risk - HIGH PRIORITY

This is your most dangerous concern. Your patient likely has:

  • Electrolyte abnormalities from dialysis
  • Heart failure (EF 27%) with potential baseline QT prolongation
  • Possible concurrent medications that prolong QT

Before administering:

  • Obtain baseline ECG and measure QTc
  • Check potassium, magnesium, calcium (correct if abnormal)
  • Review medication list for other QT-prolonging drugs 1

Metoclopramide itself prolongs QT 1. Adding chlorpromazine or haloperidol creates additive risk. If QTc >500 msec or >60 msec above baseline, do not add these agents.

Cardiovascular Instability

Both agents cause:

  • Orthostatic hypotension (less relevant in ICU but affects hemodynamics)
  • Potential for arrhythmias beyond QT prolongation 1

Your patient has severe heart failure (EF 27%). Monitor blood pressure closely and have vasopressor support readily available if needed.

Extrapyramidal Symptoms (EPS)

The combination of metoclopramide + chlorpromazine/haloperidol increases EPS risk 3. In your tracheostomized, critically ill patient with MCA infarct, detecting dystonic reactions may be challenging.

Have diphenhydramine 50 mg IV immediately available at bedside for acute dystonic reactions 1, 3. Benztropine 1-2 mg IM is an alternative 3.

Neuroleptic Malignant Syndrome (NMS)

Rare but potentially fatal with antipsychotics 3. Monitor for:

  • Hyperthermia
  • Muscle rigidity
  • Altered consciousness
  • Autonomic instability

Your patient's baseline neurologic status from MCA infarct makes this harder to detect. Maintain high suspicion if unexplained fever or rigidity develops.

Alternative Approach: Baclofen

If QTc concerns or cardiovascular instability preclude antipsychotics, consider baclofen 5-10 mg PO/NG three times daily. This GABA-B agonist has evidence for hiccups without the cardiac risks, though it's not mentioned in the provided guidelines. Adjust dose for renal function (your patient may need 5 mg daily or every other day given dialysis dependence).

Medication Reconciliation Critical

Given your patient's complexity (dialysis, multiple comorbidities, tracheostomy), perform comprehensive medication reconciliation before adding any agent 4. Ensure no drug-drug interactions with current regimen, particularly:

  • Other QT-prolonging drugs (common in ICU: ondansetron, fluoroquinolones, azithromycin) 1
  • CNS depressants that could worsen sedation
  • Drugs metabolized similarly that could accumulate

Monitoring Protocol

Once chlorpromazine/haloperidol is started:

  1. Continuous cardiac monitoring for first 24 hours
  2. Daily ECG with QTc measurement
  3. Electrolytes every 12-24 hours (especially around dialysis)
  4. Neurologic checks every 4 hours for EPS/NMS
  5. Blood pressure monitoring (already standard in ICU)

Duration and Reassessment

Hiccups in critically ill patients often resolve with treatment of underlying conditions (pneumonia, uremia, CNS pathology). Reassess need for hiccup-specific therapy every 48-72 hours. Do not continue antipsychotics longer than necessary given TD risk, though this is primarily a concern with chronic use 3.

Common Pitfall to Avoid

Do not simply increase metoclopramide dose. Your patient is already on a therapeutic dose. Metoclopramide carries its own serious risks (tardive dyskinesia, NMS, EPS) that worsen with higher doses and longer duration 3. The FDA specifically warns against prolonged use beyond 12 weeks, and even short-term high doses increase risk in vulnerable populations (elderly, diabetics, women) - your patient has diabetes 3.

Related Questions

For a 53-year-old male with heart failure (ejection fraction 27%), malignant cerebrovascular disease (left middle cerebral artery infarct), resolving pneumonia, type 2 diabetes mellitus, acute kidney injury on chronic kidney disease on hemodialysis, status post tracheostomy, currently on mechanical ventilation with FiO2 40% in volume‑assist control mode, breathing rate 20 breaths per minute, tidal volume 400 mL, what initial pressure‑assist‑control (PAC) settings should be used?
What is the appropriate management of acute kidney injury secondary to blood loss in an adult patient?
Is acute kidney injury defined by an elevation of serum creatinine that persists for only three months?
What is the recommended management algorithm for acute kidney injury?
What else can be done for a 70‑year‑old white female with congestive heart failure, chronic obstructive pulmonary disease, atrial fibrillation, acute and chronic respiratory failure, oxygen dependence, hypertension, chronic kidney disease, who is taking amiodarone 200 mg, dapagliflozin 5 mg, and furosemide 60 mg, and complains of shortness of breath?
What are the possible causes and recommended workup for a patient with a normal FEV1/FVC ratio, normal FEV1 and FVC, but a reduced diffusing capacity of the lungs for carbon monoxide (DLCO)?
In a patient with chronic benzodiazepine use who presents with a Glasgow Coma Scale of 8, should flumazenil be administered?
How should I manage a patient with burning dry mouth who tested negative for Sjögren’s syndrome?
In a 65‑year‑old woman with memory concerns, which of her current medications (including famotidine (Peptic), omeprazole (Prilosec), losartan (Cozaar), gabapentin (Neurontin), cyclosporine (Restasis), fluticasone nasal spray (Flonase), albuterol, cyclobenzaprine (Flexeril), fluconazole (Diflucan), and others) are likely contributing to her memory loss?
Can taking levothyroxine (Synthroid) 50 µg and then pantoprazole 30 minutes later affect their efficacy, and how should they be timed if both must be taken 30 minutes before food?
What other conditions can present with symptoms similar to gastritis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.